News

Medicare fraud

The former proprietor of a pharmacy in New Jersey was caught billing federal insurance for prescriptions of the antibiotic Dificid at $4,000 a pop, despite providers never ordering the pills. He pleaded guilty to charges of healthcare fraud conspiracy in November 2025.

smartphone and laptop

Do: Use large-language AI to help analyze your specific symptoms. Don’t: Ask a chatbot if you should go to the emergency room.

telehealth telemedicine

If Congress doesn’t act soon, CMS’s flexible funding of telemedicine visits—a temporary holdover from the COVID era—will dry up next year. A new study may help persuade fiscally cautious representatives not to let that happen.

obesity semaglutide tirzepatide GLP-1 drugs weight loss

In a survey, employers told the Business Group on Health that they aren’t yet seeing evidence of long-term health benefits from taking GLP-1s for weight loss, leaving them unsure how to manage costs while continuing to cover them.

KardiaPSI Balloon Catheter Corvention

The new device from Arizona-based Corvention was built to withstand the extreme pressures associated with treating severely calcified valves. 

Boston Scientific's Seismiq 4CE Coronary IVL Catheter

The company's Seismiq platform has already gained FDA approval for treating PAD. This new analysis highlights its potential to treat calcified coronary lesions during PCI procedures.

American Society of Nuclear Cardiology (ASNC) Jamieson Bourque, MD, MHS, FASNC, a professor and the director of nuclear cardiology at the University of Virginia, explains the key federal policies impacting cardiology that were discussed with lawmakers on Capital Hill last week.

The American Society of Nuclear Cardiology visited Capitol Hill to advocate for a variety of issues. Cardiovascular Business spoke to the group's president to learn more.

Harold Litt, MD

Litt, a leading name in the fields of radiology and cardiology, has been with the journal since it was first launched in 2019. 

Thumbnail

First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer. 

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.

The agency said the new program, made possible by Medicare Part D, begins on July 1 and will extend until the end of 2027. For $50 a month, Medicare beneficiaries will be able to access popular weight loss drugs, in hopes they will improve overall health.

emergency department

The perception is probably more pronounced in community hospital EDs than their academic counterparts. 

Medical malpractice gavel diagnostic error mistake stethoscope

In a lawsuit, the daughters of a deceased patient accuse Alegent Health-Community Memorial Hospital of Missouri Valley of medical malpractice and negligence, alleging donations were harvested without proper consultation. It’s alleged that their father was not registered as an organ donor.

Around the web

The former proprietor of a pharmacy in New Jersey was caught billing federal insurance for prescriptions of the antibiotic Dificid at $4,000 a pop, despite providers never ordering the pills. He pleaded guilty to charges of healthcare fraud conspiracy in November 2025.

Do: Use large-language AI to help analyze your specific symptoms. Don’t: Ask a chatbot if you should go to the emergency room.

If Congress doesn’t act soon, CMS’s flexible funding of telemedicine visits—a temporary holdover from the COVID era—will dry up next year. A new study may help persuade fiscally cautious representatives not to let that happen.